1SB
GSK icon

1ST Source Bank’s GSK GSK Stock Holding History

1ST Source Bank’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,763
Closed -$205K – 244
2022
Q2 		$205K Sell
3,763
-115
-3% -$6.35K 0.01% 240
2022
Q1 		$211K Buy
3,878
+40
+1% +$2.17K 0.01% 257
2021
Q4 		$212K Buy
+3,838
New +$200K 0.01% 259
2021
Q3 		– Sell
-4,229
Closed -$210K – 265
2021
Q2 		$210K Sell
4,229
-316
-7% -$15.2K 0.01% 259
2021
Q1 		$203K Sell
4,545
-40
-0.9% -$1.82K 0.01% 251
2020
Q4 		$211K Buy
4,585
+88
+2% +$4.04K 0.02% 234
2020
Q3 		$212K Sell
4,497
-7,061
-61% -$354K 0.02% 208
2020
Q2 		$589K Sell
11,558
-588
-5% -$30.2K 0.05% 146
2020
Q1 		$575K Buy
12,146
+5,040
+71% +$269K 0.06% 138
2019
Q4 		$417K Buy
7,106
+950
+15% +$52.8K 0.03% 169
2019
Q3 		$328K Buy
6,156
+668
+12% +$34.4K 0.03% 182
2019
Q2 		$275K Buy
5,488
+4
+0.1% +$201 0.02% 197
2019
Q1 		$286K Buy
5,484
+1,286
+31% +$64.3K 0.02% 189
2018
Q4 		$201K Sell
4,198
-380
-8% -$18.7K 0.02% 207
2018
Q3 		$230K Buy
+4,578
New +$233K 0.02% 211
2018
Q2 		– Sell
-4,244
Closed -$207K – 233
2018
Q1 		$207K Buy
+4,244
New +$198K 0.02% 223
2017
Q4 		– Sell
-4,206
Closed -$213K – 235
2017
Q3 		$213K Buy
4,206
+65
+2% +$3.3K 0.02% 215
2017
Q2 		$223K Sell
4,141
-37
-0.9% -$1.97K 0.02% 209
2017
Q1 		$220K Sell
4,178
-529
-11% -$26.8K 0.02% 218
2016
Q4 		$227K Buy
4,707
+57
+1% +$2.82K 0.02% 216
2016
Q3 		$251K Buy
+4,650
New +$255K 0.03% 198

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

1ST Source Bank's GSK Position: Q3 2022 in Review

1ST Source Bank sold out of GSK (GSK) in Q3 2022, closing a stake of 3,763 shares — an estimated $205K sold.

1ST Source Bank first reported a position in GSK in Q3 2016 and held it in 21 quarters. The position peaked at $589K in Q2 2020. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • 1ST Source Bank reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
  • 1ST Source Bank sold 3,763 GSK shares in Q3 2022, an estimated $205K.
  • 1ST Source Bank first reported a position in GSK in Q3 2016 and held it in 21 quarters.
  • 1ST Source Bank's GSK position peaked at $589K in Q2 2020.
  • 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on 1ST Source Bank's 13F filing for Q3 2022, filed 4 Nov 2022.